breast mucinous carcinoma
breast mucinous carcinoma
Explore linked clinical trials. Standard reference: MONDO:00027072 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women | Carcinoma, Ductal, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Ductal, Lobular, and Medullary, Skin and Connective Tissue Diseases, adenocarcinoma, breast disorder, breast ductal adenocarcinoma, breast mucinous carcinoma, breast neoplasm, carcinoma, epithelial neoplasm, invasive tubular breast carcinoma, neoplasm, skin disorder | Recruiting | Phase 3 | 2025-05-16 | NCT03201861 | |
| Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients | Carcinoma, Ductal, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Ductal, Lobular, and Medullary, Skin and Connective Tissue Diseases, adenocarcinoma, breast disorder, breast ductal adenocarcinoma, breast mucinous carcinoma, breast neoplasm, carcinoma, epithelial neoplasm, inflammatory breast carcinoma, invasive tubular breast carcinoma, neoplasm, skin disorder | Active, not recruiting | Phase 2 / Phase 3 | 2023-08-29 | NCT02221999 |